Gildan Activewear (GIL) traded lower Thursday, down about 3.36% to roughly $54.86, as attention shifted to governance items disclosed in recently circulated 2026 annual-meeting materials. The company is asking shareholders at its April 30, 2026 annual and special meeting to approve, ratify, and renew its shareholder rights plan (often referred to as a “poison pill”), replacing an existing plan that expires at the meeting unless renewed. (stocktitan.net)

Rights plans are designed to deter hostile takeovers and can be viewed as limiting a potential control premium for shareholders. The proxy language also notes that while the plan is initially not dilutive, a triggering event could lead to substantial dilution for holders who do not exercise rights—an added reminder of the high-stakes nature of the governance vote. (stocktitan.net)

The key near-term catalyst is the April 30, 2026 shareholder meeting and the outcome of the rights-plan renewal vote. Investors will also monitor whether any activists, large holders, or governance-focused institutions publicly push for changes ahead of the meeting, and whether the company provides additional context on why the plan is being renewed now. (marketscreener.com)

GIL’s move also fits a pattern often seen around proxy-season governance items, where incremental filings can spark short-term volatility even without a change to core operating guidance. With the stock having traded strongly at times into 2026, governance uncertainty can be enough to trigger a bout of de-risking and profit-taking on a down day. (marketscreener.com)